Skip to main content

Table 1 GeneChip analysis of downregulated genes after 25-HC treatment of Huh-7 cells and Huh-7 cells bearing HCV subgenomic replicons.a

From: Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus

 

Descriptionb

Name

Accession #

Fold change 25-HC-treated

Fold change 25-HC-treated HCV replicon

1

chromosome 14 clone BAC 507E23 map 14q24.3

B-ATF

AC007182

-4.1

-6.4

2

mRNA for cysteine protease

 

D55696.1

-3.9

---

3

RNA binding motif protein 5

RBM5

NM_005778.1

-3.1

---

4

tetratricopeptide repeat domain 3

TTC3

AI652848

-3.1

---

5

insulin induced gene 1

INSIG1

BE300521

-2.8

-2.9

   

BG292233

-2.2

-1.9

   

NM_005542.1

-2.2

-2

6

SON DNA binding protein

SON

AA664291

-2.4

-2.4

7

3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble)

HMGCS1

NM_002130.1

-2.4

-2.4

8

Similar to Nedd-4-like ubiquitin-protein ligase, clone MGC:2079

 

BC000108.1

-2.3

---

9

hypothetical protein DJ328E19.C1.1

DJ328E19.C1.1

BE732345

-2.3

---

10

Human DNA sequence from clone RP1-221C16 on chromosome 6

 

AL353759

-2.2

---

11

low density lipoprotein receptor

LDLR

AI861942

-2.1

-3.3

12

3-hydroxy-3-methylglutaryl-Coenzyme A reductase

HMGCR

AL518627

-2.1

-1.9

13

fatty acid desaturase 1

FADS1

BG165833

-2.1

-1.7

14

sterol-C5-desaturase homolog

 

D85181.1

-2.1

---

15

Human lanosterol 14-alpha demethylase

CYP51P2

U40053

-2.1

-2

16

FK506-binding protein 2

FKBP2

NM_004470.1

-2

-1.6

17

apolipoprotein AI regulatory protein

ARP-1

M64497.1

-2

-3.5

18

Homo sapiens HDCMC28P protein

HDCMC28P

NM_016649.1

-2

---

19

pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 1

PLEKHA1

NM_021622.1

-2

---

20

olfactory receptor, family 7, subfamily A, member 17

OR7A17

NM_030901.1

-1.9

2.4

21

sterol-C4-methyl oxidase-like

SC4MOL

AV704962

-1.9

-2.5

22

PRO0998

PRO0998

AF116616.1

-1.9

-2.6

23

ASMneg1-b1 immunoglobulin lambda chain VJ region

IGL

AF043584.1

-1.9

1.7

24

bone marrow protein BM037

BM037

NM_018454.1

-1.9

---

25

3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1

HMGCS1

BG035985

-1.9

-2.6

26

farnesyl diphosphate synthase

FDPS

NM_002004.1

-1.8

-1.8

27

mevalonate (diphospho) decarboxylase

MVD

AI189359

-1.8

-3.1

28

kinesin family member 3C

KIF3C

NM_002254.1

-1.8

---

29

peptidyl-prolyl isomerase G (cyclophilin G)

PPIG

AW340788

-1.8

---

30

acetyl-Coenzyme A acetyltransferase 2

 

BC000408.1

-1.8

-1.6

31

farnesyl-diphosphate farnesyltransferase 1

 

BC003573.1

-1.8

-2

32

Homo sapiens Kruppel-like factor

LOC51713

NM_016270.1

-1.8

-2.4

33

prospero-related homeobox 1

PROX1

NM_002763.1

-1.7

---

34

cDNA FLJ13484 fis, clone PLACE1003888

 

AK023546.1

-1.7

---

35

M10098 Human 18S rRNA sequence

  

-1.7

---

36

chromodomain helicase DNA binding protein 4

CHD4

AI761771

-1.6

-2.1

37

topoisomerase (DNA) II alpha 170kDa

TOP2A

AU159942

-1.6

---

38

7-dehydrocholesterol reductase

DHCR7

AW150953

-1.6

-2.2

39

vesicle docking protein p115

VDP

BE875592

-1.6

-1.5

40

v-crk avian sarcoma virus CT10 oncogene homolog

CRK

NM_016823.1

-1.6

1.7

41

Nijmegen breakage syndrome 1 (nibrin)

NBS1

AI796269

-1.6

---

42

farnesyl-diphosphate farnesyltransferase 1

FDFT1

AA872727

-1.6

-2.2

43

cDNA FLJ11371 fis, clone HEMBA1000356

 

AK021433.1

-1.6

---

44

PAC clone RP5-979P20 from 7

NPM1P12

AC004941

-1.6

-1.5

45

erythrocyte membrane protein band 4.1-like 2

EPB41L2

BF511685

-1.5

1.9

46

activated leukocyte cell adhesion molecule

ALCAM

BF242905

-1.5

-1.7

47

protein kinase related to S. cerevisiae STE20

PAK4

NM_005884.2

-1.5

---

48

cDNA: FLJ21342 fis, clone COL02673.

 

AK024995.1

-1.5

---

  1. a Fold change was calculated from the average of two independent hybridizations on U133A Affymetrix GeneChip arrays compared with an average expression value from analogous hybridizations from control cells that were not treated with 25-HC. Fold change for 25-HC-treated column was determined from the ratio of expression in 25-HC treated Huh-7 cells/naĂŻve Huh-7 cells and for the 25-HC-treated HCV replicon column from the ratio of expression values from (replicon + 25-HC)/replicon. b Italicized entries are known to be involved in the mevalonate pathway. Dashes (---) indicate genes whose fold-change in gene expression did not exceed 1.5-fold and hence were omitted from the analysis.